Global mRNA Vaccines & Therapeutics Market Size, Share, Trends and Forecast 2022-2030

Description

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
Industry Insights

Due to the COVID-19 pandemic, the global mRNA Vaccines & Therapeutics market size is estimated to be worth US$ 36680 million in 2021 and is forecast to a readjusted size of US$ 1575.4 million by 2028 with a CAGR of -14.0% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe mRNA Vaccines & Therapeutics market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe mRNA Vaccines & Therapeutics landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Global core mRNA vaccines & therapeutics manufacturers include Moderna Therapeutics, CureVac etc. The top 3 companies hold a share about 65%. Europe is the largest market, with a share about 10%, followed by Asia Pacific and North America.

This report focuses on mRNA Vaccines & Therapeutics volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall mRNA Vaccines & Therapeutics market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the mRNA Vaccines & Therapeutics market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Infectious Disease Vaccines

Cancer Vaccines

Segment by Application

Infectious Disease

Cancer

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Moderna Therapeutics

CureVac

Translate Bio

BioNTech

Sangamo Therapeutics

Argos Therapeutics

In-Cell-Art

eTheRNA

Ethris

Tiba Biotechnology

TABLE OF CONTENT

1 mRNA Vaccines & Therapeutics Market Overview
1.1 Product Overview and Scope of mRNA Vaccines & Therapeutics

1.2 mRNA Vaccines & Therapeutics Segment by Type

1.2.1 Global mRNA Vaccines & Therapeutics Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Infectious Disease Vaccines

1.2.3 Cancer Vaccines

1.3 mRNA Vaccines & Therapeutics Segment by Application

1.3.1 Global mRNA Vaccines & Therapeutics Sales Comparison by Application: (2022-2028)

1.3.2 Infectious Disease

1.3.3 Cancer

1.4 Global mRNA Vaccines & Therapeutics Market Size Estimates and Forecasts

1.4.1 Global mRNA Vaccines & Therapeutics Revenue 2017-2028

1.4.2 Global mRNA Vaccines & Therapeutics Sales 2017-2028

1.4.3 mRNA Vaccines & Therapeutics Market Size by Region: 2017 Versus 2021 Versus 2028

2 mRNA Vaccines & Therapeutics Market Competition by Manufacturers

2.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturers (2017-2022)

2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturers (2017-2022)

2.3 Global mRNA Vaccines & Therapeutics Average Price by Manufacturers (2017-2022)

2.4 Manufacturers mRNA Vaccines & Therapeutics Manufacturing Sites, Area Served, Product Type

2.5 mRNA Vaccines & Therapeutics Market Competitive Situation and Trends

2.5.1 mRNA Vaccines & Therapeutics Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest mRNA Vaccines & Therapeutics Players Market Share by Revenue

2.5.3 Global mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 mRNA Vaccines & Therapeutics Retrospective Market Scenario by Region

3.1 Global mRNA Vaccines & Therapeutics Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global mRNA Vaccines & Therapeutics Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America mRNA Vaccines & Therapeutics Market Facts & Figures by Country

3.3.1 North America mRNA Vaccines & Therapeutics Sales by Country

3.3.2 North America mRNA Vaccines & Therapeutics Revenue by Country

3.3.3 United States

3.3.4 Canada

3.4 Europe mRNA Vaccines & Therapeutics Market Facts & Figures by Country

3.4.1 Europe mRNA Vaccines & Therapeutics Sales by Country

3.4.2 Europe mRNA Vaccines & Therapeutics Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific mRNA Vaccines & Therapeutics Market Facts & Figures by Region

3.5.1 Asia Pacific mRNA Vaccines & Therapeutics Sales by Region

3.5.2 Asia Pacific mRNA Vaccines & Therapeutics Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.6 Latin America mRNA Vaccines & Therapeutics Market Facts & Figures by Country

3.6.1 Latin America mRNA Vaccines & Therapeutics Sales by Country

3.6.2 Latin America mRNA Vaccines & Therapeutics Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa mRNA Vaccines & Therapeutics Market Facts & Figures by Country

3.7.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country

3.7.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global mRNA Vaccines & Therapeutics Historic Market Analysis by Type

4.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2022)

4.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2017-2022)

4.3 Global mRNA Vaccines & Therapeutics Price by Type (2017-2022)

5 Global mRNA Vaccines & Therapeutics Historic Market Analysis by Application

5.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2022)

5.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2017-2022)

5.3 Global mRNA Vaccines & Therapeutics Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Moderna Therapeutics

6.1.1 Moderna Therapeutics Corporation Information

6.1.2 Moderna Therapeutics Description and Business Overview

6.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Portfolio

6.1.5 Moderna Therapeutics Recent Developments/Updates

6.2 CureVac

6.2.1 CureVac Corporation Information

6.2.2 CureVac Description and Business Overview

6.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2017-2022)

6.2.4 CureVac mRNA Vaccines & Therapeutics Product Portfolio

6.2.5 CureVac Recent Developments/Updates

6.3 Translate Bio

6.3.1 Translate Bio Corporation Information

6.3.2 Translate Bio Description and Business Overview

6.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Translate Bio mRNA Vaccines & Therapeutics Product Portfolio

6.3.5 Translate Bio Recent Developments/Updates

6.4 BioNTech

6.4.1 BioNTech Corporation Information

6.4.2 BioNTech Description and Business Overview

6.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2017-2022)

6.4.4 BioNTech mRNA Vaccines & Therapeutics Product Portfolio

6.4.5 BioNTech Recent Developments/Updates

6.5 Sangamo Therapeutics

6.5.1 Sangamo Therapeutics Corporation Information

6.5.2 Sangamo Therapeutics Description and Business Overview

6.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Portfolio

6.5.5 Sangamo Therapeutics Recent Developments/Updates

6.6 Argos Therapeutics

6.6.1 Argos Therapeutics Corporation Information

6.6.2 Argos Therapeutics Description and Business Overview

6.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Product Portfolio

6.6.5 Argos Therapeutics Recent Developments/Updates

6.7 In-Cell-Art

6.6.1 In-Cell-Art Corporation Information

6.6.2 In-Cell-Art Description and Business Overview

6.6.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2017-2022)

6.4.4 In-Cell-Art mRNA Vaccines & Therapeutics Product Portfolio

6.7.5 In-Cell-Art Recent Developments/Updates

6.8 eTheRNA

6.8.1 eTheRNA Corporation Information

6.8.2 eTheRNA Description and Business Overview

6.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2017-2022)

6.8.4 eTheRNA mRNA Vaccines & Therapeutics Product Portfolio

6.8.5 eTheRNA Recent Developments/Updates

6.9 Ethris

6.9.1 Ethris Corporation Information

6.9.2 Ethris Description and Business Overview

6.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2017-2022)

6.9.4 Ethris mRNA Vaccines & Therapeutics Product Portfolio

6.9.5 Ethris Recent Developments/Updates

6.10 Tiba Biotechnology

6.10.1 Tiba Biotechnology Corporation Information

6.10.2 Tiba Biotechnology Description and Business Overview

6.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2017-2022)

6.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Portfolio

6.10.5 Tiba Biotechnology Recent Developments/Updates

7 mRNA Vaccines & Therapeutics Manufacturing Cost Analysis

7.1 mRNA Vaccines & Therapeutics Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of mRNA Vaccines & Therapeutics

7.4 mRNA Vaccines & Therapeutics Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 mRNA Vaccines & Therapeutics Distributors List

8.3 mRNA Vaccines & Therapeutics Customers

9 mRNA Vaccines & Therapeutics Market Dynamics

9.1 mRNA Vaccines & Therapeutics Industry Trends

9.2 mRNA Vaccines & Therapeutics Market Drivers

9.3 mRNA Vaccines & Therapeutics Market Challenges

9.4 mRNA Vaccines & Therapeutics Market Restraints

10 Global Market Forecast

10.1 mRNA Vaccines & Therapeutics Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of mRNA Vaccines & Therapeutics by Type (2023-2028)

10.1.2 Global Forecasted Revenue of mRNA Vaccines & Therapeutics by Type (2023-2028)

10.2 mRNA Vaccines & Therapeutics Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of mRNA Vaccines & Therapeutics by Application (2023-2028)

10.2.2 Global Forecasted Revenue of mRNA Vaccines & Therapeutics by Application (2023-2028)

10.3 mRNA Vaccines & Therapeutics Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of mRNA Vaccines & Therapeutics by Region (2023-2028)

10.3.2 Global Forecasted Revenue of mRNA Vaccines & Therapeutics by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample